Read more on M - The Explorer Magazine

Fighting Cancer with Precision Medicine

A large number of patients who suffer from advanced colorectal cancer benefit from an antibody therapy....more

A large number of patients who suffer from advanced colorectal cancer benefit from an antibody therapy. In these cases, personalized medicine is the key to optimal therapeutic outcomes.

Read more on M - The Explorer Magazine

Social commitment in Rio de Janeiro

Brazil is an up-and-coming country of strong contrasts. A growing middle class is flanked by unimaginable...more

Brazil is an up-and-coming country of strong contrasts. A growing middle class is flanked by unimaginable wealth on the one hand and bitter poverty on the other. EMD employees in Brazil are involved in many projects for the disadvantaged.

ArticleNext Article<

A company that is synonymous with innovation

We are committed to making great things happen. That is what our workforce of around 39,000 men and women are aiming for each and every day.

INNOVATION KEY FACTS

Innovation Key Facts

RESEARCH ACTIVITIES

Research Activities

GRANTS & AWARDS

Grants & Awards

M - THE EXPLORER MAGAZINE

M - The Explorer Magazine

DISCLAIMER

Publication of Merck KGaA, Darmstadt, Germany.
In the United States and Canada the subsidiaries of Merck KGaA, Darmstadt, Germany, operate under the umbrella brand EMD.
 
 
  
Read more on M - The Explorer Magazine

Fighting Cancer with Precision Medicine

A large number of patients who suffer from advanced colorectal cancer benefit from an antibody therapy. In these cases, personalized medicine is the key to optimal therapeutic outcomes.

Read more on M - The Explorer Magazine
Read more on M - The Explorer Magazine

Social commitment in Rio de Janeiro

Brazil is an up-and-coming country of strong contrasts. A growing middle class is flanked by unimaginable wealth on the one hand and bitter poverty on the other.

Read more on M - The Explorer Magazine